Cargando…
Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
ILA/ILD extension and subpleural ILA localisation are risk factors for disease progression in RA subjects. A semiquantitative method to assess ILA/ILD extent and to measure the fibrotic burden is feasible to accurately determine ILA progression. https://bit.ly/3mmMJk2
Autores principales: | Leone, Paolo Maria, Richeldi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910034/ https://www.ncbi.nlm.nih.gov/pubmed/33664837 http://dx.doi.org/10.1183/20734735.0223-2020 |
Ejemplares similares
-
Assembly 12: interstitial lung diseases
por: Antoniou, Katerina, et al.
Publicado: (2018) -
Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
por: Finney, Lydia J.
Publicado: (2019) -
Interstitial lung disease with usual interstitial pneumonia pattern preceding the presentation of ANCA-associated vasculitis by 4 years: coincidence or correlation?
por: Kishore, Nevin, et al.
Publicado: (2018) -
Expert Opinion Guidance on the Detection of Early Connective Tissue Diseases in Interstitial Lung Disease
por: Namas, Rajaie, et al.
Publicado: (2023) -
Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need
por: Goodwin, Amanda T., et al.
Publicado: (2020)